Meditech contracts $4.4m from the state of Kosovo, achieves the record 80 million during Kurti Government

The Health Ministry (MSH), which is headed by incumbent Minister Arben Vitita, has even rewarded a tender of nothing less than 4.4m euros to the Mediterranean Company, in which the shareholder is also the former AKPM director Arian Jakupi. A few days ago Front Online had published another research in which he reported [...]

A few days ago Front Online had also published a research in which it had reported that more than 153 public contracts in a value exceeding 75m euros, have benefited the pharmaceutical company” Meditch”, mainly from the Ministry of Health (MSH) and the Kosovo University Clinical Service (SHSKUK). The period of profits included the years 2021 to 2025, and for the sum, this company ranks among the largest beneficiaries from the state budget in the drug sector.
According to secured documents, the 4.4m-euro Mediterranean company has won the tender for supply with Ocrelizumab which is a modern biological drug used to treat multiple sclerosis
According to secured documents, the Mediterranean company has won the tender for supply with 1,200 centrists. Ocrelizumab which, according to a simple estimate, was over 3600 euros in cash.












